Neogen Chemicals Approves Un-audited Financial Results for Quarter Ended Sep 30, 2025
Neogen Chemicals approves results for quarter ended Sep 30, 2025. Addresses notices from BSE/NSE regarding regulatory non-compliance. Notes fire incident at Dahej plant and insurance claim. Scheme of Amalgamation of Buli Chemicals approved.
The financial results and regulatory issues have a moderate impact on the company, while the fire incident is already accounted for with insurance claims.
The announcement contains both positive (financial results approval) and negative (regulatory non-compliance, fire incident) aspects, balancing the sentiment to neutral.
* Neogen Chemicals Limited approved the un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2025, in a board meeting held on November 8, 2025. * The company received notices from BSE and NSE regarding non-compliance with Regulation 17(1A) for not specifically mentioning it in the special resolution for re-appointment of an Independent Director who was attaining 75 years. * Fines were levied for the quarter ended June 30, 2025, and the company applied for a waiver on September 10, 2025, awaiting a response. * The company had a fire at its Dahej SEZ Plant on March 05, 2025, which damaged property, plant, equipment, and inventory. An insurance claim was submitted, and ₹80 crore and ₹30 crore were received as on account payment from the insurance company during the quarter ended June 30, 2025 and September 30, 2025 respectively. * The Scheme of Amalgamation of Buli Chemicals India Private Limited with Neogen Chemicals Limited was approved with effect from April 1, 2024. * The company listed Non-Convertible Debentures (NCDs) of ₹200 crore and term loan of ₹65.00 crore raised from another lender are having Subservient charge over immovable assets at Karakhadi and Dahej and all the movable asset of the company, rest other loan are secured by way of charge on all movable and immovable assets of the company.
What to do with a filing like this
Neogen Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Neogen Chemicals Limited. Read the original for the full detail.